Kudo, M., Okusaka, T., Motomura, K., Ohno, I., Morimoto, M., Seo, S., . . . Zhu, A. X. (2020). Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial. J Gastroenterol.
Trích dẫn kiểu ChicagoKudo, Masatoshi, et al. "Ramucirumab After Prior Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Elevated Alpha-fetoprotein: Japanese Subgroup Analysis of the REACH-2 Trial." J Gastroenterol 2020.
Trích dẫn MLAKudo, Masatoshi, et al. "Ramucirumab After Prior Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Elevated Alpha-fetoprotein: Japanese Subgroup Analysis of the REACH-2 Trial." J Gastroenterol 2020.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.